{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:06:39Z","timestamp":1772820399829,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11882-001-0064-9","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T18:53:58Z","timestamp":1180810438000},"page":"550-557","source":"Crossref","is-referenced-by-count":11,"title":["The pathogenesis of allergic conjunctivitis"],"prefix":"10.1007","volume":"1","author":[{"given":"Andrea","family":"Keane-Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"64_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clin.1997.4507","volume":"87","author":"MT Magone","year":"1998","unstructured":"Magone MT, Chan C-C, Rizzo LV, et al.: A novel murine model of allergic conjunctivitis. Clin Immunol Immunopathol 1998, 87:75\u201384.","journal-title":"Clin Immunol Immunopathol"},{"key":"64_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0039-6257(93)90036-7","volume":"38","author":"MB Abelson","year":"1993","unstructured":"Abelson MB, Schaefer K: Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993, 38(Suppl):115\u2013132.","journal-title":"Surv Ophthalmol"},{"key":"64_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0039-6257(93)90035-6","volume":"38","author":"MH Friedlaender","year":"1993","unstructured":"Friedlaender MH: Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Surv Ophthamol 1993, 38:105\u2013114.","journal-title":"Surv Ophthamol"},{"key":"64_CR4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/archopht.1984.01040030976029","volume":"102","author":"MH Friedlaender","year":"1984","unstructured":"Friedlaender MH, Okumoto M, Kelley J: Diagnosis of allergic conjunctivitis. Arch Ophthamol 1984, 102:1198\u20131199.","journal-title":"Arch Ophthamol"},{"key":"64_CR5","first-page":"1","volume":"2","author":"L Bielory","year":"2000","unstructured":"Bielory L: Ocular allergy. Respir Digest 2000, 2:1\u20139.","journal-title":"Respir Digest"},{"key":"64_CR6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0091-6749(95)70255-5","volume":"96","author":"EA Pastorello","year":"1995","unstructured":"Pastorello EA, Incorvaia C, Ortolani C, et al.: Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol 1995, 96:580\u2013587.","journal-title":"J Allergy Clin Immunol"},{"key":"64_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000060749","volume":"30","author":"S Bonini","year":"1999","unstructured":"Bonini S, Lambiase A, Juhas T: Allergic conjunctivitis. Dev Ophthalmol 1999, 30:54\u201361.","journal-title":"Dev Ophthalmol"},{"key":"64_CR8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.1997.03550220048008","volume":"278","author":"R Naclerio","year":"1997","unstructured":"Naclerio R, Solomon W: Rhinitis and inhalant antigens. JAMA 1997, 278:1842\u20131848.","journal-title":"JAMA"},{"key":"64_CR9","first-page":"1350","volume":"38","author":"H Fujishima","year":"1997","unstructured":"Fujishima H, Saito I, Takeuchi T, et al.: Characterization of cytokine mRNA transcripts in conjunctival cells in patients with allergic conjunctivitis. Ophthalmol Vis Sci 1997, 38:1350\u20131357.","journal-title":"Ophthalmol Vis Sci"},{"key":"64_CR10","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.155.4.2020","volume":"155","author":"A Keane-Myers","year":"1995","unstructured":"Keane-Myers A, Nickell SP: Role of IL-4 and IFN-g in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995, 155:2020\u20132028.","journal-title":"J Immunol"},{"key":"64_CR11","first-page":"336","volume":"39","author":"EB Cook","year":"1998","unstructured":"Cook EB, Stahl JL, Miller ST, et al.: Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor- a from mast cells affects intracellular adhesion molecule 1 expression on epithelial cells. Invest Ophthalmol Vis Sci 1998, 39:336\u2013343.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000267025","volume":"22","author":"A Leonardi","year":"1990","unstructured":"Leonardi A, Bloch K, Briggs R, Allansmith M: Histology of ocular late-phase reaction in guinea pigs passively sensitized with IgG1 antibodies. Ophthalmic Res 1990, 22:209\u2013219.","journal-title":"Ophthalmic Res"},{"key":"64_CR13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/exer.1997.0362","volume":"65","author":"A Fukushima","year":"1997","unstructured":"Fukushima A, Yoshida H, Iwamoto H, et al.: The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis in rats. Exp Eye Res 1997, 65:631\u2013637.","journal-title":"Exp Eye Res"},{"key":"64_CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/02713689509003760","volume":"14","author":"J Merayo-Lloves","year":"1994","unstructured":"Merayo-Lloves J, Calonge M, Foster CS: Experimental model of allergic conjunctivitis to ragweed in guinea pig. Curr Eye Res 1994, 14:487\u2013494.","journal-title":"Curr Eye Res"},{"key":"64_CR15","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.4049\/jimmunol.159.12.6216","volume":"159","author":"S He","year":"1997","unstructured":"He S, Peng Q, Walls AF: Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997, 159:6216\u20136225.","journal-title":"J Immunol"},{"key":"64_CR16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1172\/JCI115016","volume":"87","author":"B Wershil","year":"1991","unstructured":"Wershil B, Wang Z, Gordon J, Galli S: Recruitment of neutrophils during IgE-dependent late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991, 87:446\u2013453.","journal-title":"J Clin Invest"},{"key":"64_CR17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/gast.1996.v110.pm8613053","volume":"110","author":"B Wershil","year":"1996","unstructured":"Wershil B, Furuta G, Wang Z-S, Galli S: Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996, 110:1482\u20131490.","journal-title":"Gastroenterology"},{"key":"64_CR18","first-page":"322","volume":"39","author":"AS Bacon","year":"1998","unstructured":"Bacon AS, McGill JI, Anderson DF, et al.: Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Invest Ophthalmol Vis Sci 1998, 39:322\u2013330.One of the first studies to carefully examine levels of adhesion molecules on the microvasculature of the conjunctiva. The authors found that increased levels of cell adhesion molecules on the microvasculature and the factors that regulate them are likely to be responsible for the infiltration of cells bearing their ligands and may perpetuate inflammation in the chronic forms of allergic eye disease.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Lambiase A, Marchi S, et al.: Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 2000, 107:1157\u20131163.This is one of the first large-scale, long-term studies on VKC, a chronic eosinophilic disease of the ocular surface involving IgE, non-IgEmediated mechanisms, and age-sex-related influences. The study found that although the disease has a good prognosis, severe visual impairments may result from long-standing inflammation.","journal-title":"Ophthalmology"},{"key":"64_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1600-0420.2000.078s230038.x","volume":"78","author":"R Belfort","year":"2000","unstructured":"Belfort R, Marbeck P, Hsu CC, Freitas D: Epidemiological study of 134 subjects with allergic conjunctivitis. Acta Ophthalmol Scand 2000, 78:38\u201340.","journal-title":"Acta Ophthalmol Scand"},{"key":"64_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0420.2000.078s230018.x","volume":"78","author":"A Leonardi","year":"2000","unstructured":"Leonardi A: Role of histamine in allergic conjunctivitis. Acta Ophthalmol Scand 2000, 78:18\u201321.","journal-title":"Acta Ophthalmol Scand"},{"key":"64_CR22","first-page":"1272","volume":"39","author":"A Lambiase","year":"1998","unstructured":"Lambiase A, Bonini S, Micera A, et al.: Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 1998, 39:1272\u20131275.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR23","first-page":"2161","volume":"38","author":"A Lambiase","year":"1997","unstructured":"Lambiase A, Bonini S, Micera A, et al.: Increased plasma levels of substance P in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 1997, 38:2161\u20132164.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR24","first-page":"392","volume":"40","author":"M Hingorani","year":"1999","unstructured":"Hingorani M, Calder VL, Buckley RJ, Lightman S: The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Invest Ophthalmol Vis Sci 1999, 40:392\u2013399.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00055735-200012000-00016","volume":"11","author":"MC Carnahan","year":"2000","unstructured":"Carnahan MC, Goldstein DA: Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000, 11:478\u2013483.","journal-title":"Curr Opin Ophthalmol"},{"key":"64_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","volume":"15","author":"RC Tripathi","year":"1999","unstructured":"Tripathi RC, Parapuram SK, Tripathi BJ, et al.: Corticosteroids and glaucoma risk. Drugs Aging 1999, 15:439\u2013450.","journal-title":"Drugs Aging"},{"issue":"5","key":"64_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/exer.1998.0528","volume":"67","author":"MCV Hingorani","year":"1998","unstructured":"Hingorani MCV, Buckley RJ, Lightman SL: The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res 1998, 67(5):491\u2013500.The objectives of these experiments were to compare the expression of HLA-DR, ICAM-I, and proallergic cytokines in conjunctival epithelial cells in the different chronic ocular allergic disorders with each other and with normal subjects. The authors found that the epithelial cytokines that are upregulated are known to promote eosinophilic inflammation and are typical of allergic inflammation. These differences in cytokine patterns may be exploitable for future therapy.","journal-title":"Exp Eye Res"},{"key":"64_CR28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1046\/j.1365-2222.1999.00585.x","volume":"29","author":"VL Calder","year":"1999","unstructured":"Calder VL, Jolly G, Hingorani M, et al.: Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999, 29:1214\u20131222.","journal-title":"Clin Exp Allergy"},{"key":"64_CR29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/exer.1998.0528","volume":"67","author":"M Hingorani","year":"1998","unstructured":"Hingorani M, Calder VL, Buckley RJ, Lightman SL: The role of conjunctival epithelial cells in chronic ocular allergic disease. Exp Eye Res 1998, 67:491\u2013500.","journal-title":"Exp Eye Res"},{"key":"64_CR30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0091-6749(98)70023-5","volume":"102","author":"M Hingorani","year":"1998","unstructured":"Hingorani M, Calder V, Jolly G, et al.: Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998, 102:821\u2013830.","journal-title":"J Allergy Clin Immunol"},{"key":"64_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","volume":"108","author":"MB Abelson","year":"1990","unstructured":"Abelson MB, Chambers WA, Smith LM: Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990, 108:84\u201388.","journal-title":"Arch Ophthalmol"},{"key":"64_CR32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9394(98)00044-0","volume":"125","author":"MB Abelson","year":"1998","unstructured":"Abelson MB, Spitalny L: Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol 1998, 125:797\u2013804.","journal-title":"Am J Ophthalmol"},{"key":"64_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0420.1999.tb01172.x","volume":"228","author":"MB Abelson","year":"1999","unstructured":"Abelson MB: Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl 1999, 228:38\u201342.","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"64_CR34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1398-9995.1997.tb04810.x","volume":"52","author":"S Bonini","year":"1997","unstructured":"Bonini S, Magrini L, Rotiroti G, et al.: The eosinophil and the eye. Allergy 1997, 52:44\u201347.","journal-title":"Allergy"},{"key":"64_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0420.1999.tb01173.x","volume":"228","author":"M Discepola","year":"1999","unstructured":"Discepola M, Deschenes J, Abelson M: Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl 1999, 228:43\u201346.","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"64_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","volume":"108","author":"MB Abelson","year":"1990","unstructured":"Abelson MB, Chambers WA, Smith LM: Conjunctival allergen challenge. Arch Ophthamol 1990, 108:84\u201388.","journal-title":"Arch Ophthamol"},{"key":"64_CR37","first-page":"3041","volume":"40","author":"AM Keane-Myers","year":"1999","unstructured":"Keane-Myers AM, Miyazaki D, Liu G, et al.: Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci 1999, 40:3041\u20133046.This paper on a mouse model of allergic conjunctivitis serves as the first, as well as a direct and efficient, model for testing the efficacy of cytokine antagonistic strategies in ocular immune-mediated disease.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000310686","volume":"210","author":"H Fujishima","year":"1996","unstructured":"Fujishima H, Shimazaki J, Yang H-Y, et al.: Retrospective survey of a link between cat and dog antigens and allergic conjunctivitis. Ophthalmologica 1996, 210:115\u2013118.","journal-title":"Ophthalmologica"},{"key":"64_CR39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mai.2000.104782","volume":"105","author":"R Aghayan-Ugurluoglu","year":"2000","unstructured":"Aghayan-Ugurluoglu R, Ball T, Vrtala S, et al.: Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol 2000, 105:803\u2013813.","journal-title":"J Allergy Clin Immunol"},{"key":"64_CR40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1398-9995.1994.tb02099.x","volume":"49","author":"E Taudorf","year":"1994","unstructured":"Taudorf E, Moller C, Russell MW: Secretory IgA response in oral immunotherapy. Investigation in birch pollinosis. Allergy 1994, 49:760\u2013765.","journal-title":"Allergy"},{"key":"64_CR41","first-page":"4203","volume":"41","author":"J Yamada","year":"2000","unstructured":"Yamada J, Zhu SN, Streilein JW, Dana MR: Interleukin-1 receptor antagonist therapy and induction of anterior chamberassociated immune deviation-type tolerance after corneal transplantation. Invest Ophthalmol Vis Sci 2000, 41:4203\u20134208.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1076\/ceyr.19.5.456.5292","volume":"19","author":"IJ Dekaris","year":"1999","unstructured":"Dekaris IJ, Yamada JJ, Streilein WJ, Dana RM: Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts. Curr Eye Res 1999, 19:456\u2013459.","journal-title":"Curr Eye Res"},{"key":"64_CR43","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.116.10.1351","volume":"116","author":"J Yamada","year":"1998","unstructured":"Yamada J, Dana MR, Zhu SN, et al.: Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol 1998, 116:1351\u20131357.","journal-title":"Arch Ophthalmol"},{"key":"64_CR44","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1521-4141(200007)30:7<1841::AID-IMMU1841>3.0.CO;2-E","volume":"30","author":"MT Magone","year":"2000","unstructured":"Magone MT, Chan CC, Beck L, et al.: Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur J Immunol 2000, 30:1841\u20131850.This study was the first to use ISS to specifically upregulate a protective TH1 response in a mouse model of allergic eye disease and suggests that ISS is working through IL-12.","journal-title":"Eur J Immunol"},{"key":"64_CR45","volume-title":"Microbial DNA and Immune Modulation","author":"A Keane-Myers","year":"2001","unstructured":"Keane-Myers A, Chan CC: Modulation of allergic conjunctivitis by immunostimulatory DNA sequence oligonucleotides (ISS-ODN). In Microbial DNA and Immune Modulation. Edited by Raz E. Totowa, NJ: The Humana Press; 2001."},{"key":"64_CR46","first-page":"2686","volume":"37","author":"SM Whitcup","year":"1996","unstructured":"Whitcup SM, Chan CC, Luyo DA, et al.: Topical cyclosporine inhibits mast cell-mediated conjunctivitis. Invest Ophthalmol Vis Sci 1996, 37:2686\u20132693.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"64_CR47","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","volume":"106","author":"L Bielory","year":"2000","unstructured":"Bielory L: Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000, 106:1019\u20131032.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-001-0064-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0064-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:58:25Z","timestamp":1707937105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-001-0064-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1007\/s11882-001-0064-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}